News & Events

Research highlights

April 21, 2017

Engineering the Immune System

Meld the best of immunology and the best of engineering and what do you have? The nascent field of immunoengineering.

Read on.

March 27, 2017

How Randomness Helps Cancer Cells Thrive

In a research effort that merged genetics, physics and information theory, a team at the schools of medicine and engineering at The Johns Hopkins University has added significantly to evidence that large regions of the human genome have built-in variability in reversible epigenetic modifications made to their DNA. In a report on the research published […]

Read on.

March 9, 2017

First fully artificial yeast genome has been designed

Working as part of an international research consortium, a multidisciplinary team at the Johns Hopkins University has completed the design phase for a fully synthetic yeast genome.

Read on.

February 24, 2017

New Gene Sequencing Software Could Aid in Early Detection and Treatment of Cancer

Winston Timp, an assistant professor of biomedical engineering, supervised research on new computational software that determines if a human DNA sample includes an epigenetic add-on linked to cancer and other health conditions.

Read on.

New Peptide Could Improve Treatment for Vision-Threatening Disease

January 26, 2017

New Peptide Could Improve Treatment for Vision-Threatening Disease

Johns Hopkins researchers report that a new peptide holds promise for improving treatment for degenerative retinal diseases, such as age-related macular degeneration, diabetic macular edema and diabetic retinopathy. These vascular diseases often result in central vision loss as blood vessels grow into tissues at the back of the eye, where such growth should not occur.

Read on.

January 23, 2017

Noninvasive Ultrasound Pulses Used to Precisely Tweak Rat Brain Activity

Jordan Green, associate professor of biomedical engineering, and his colleagues have figured out a noninvasive way to release and deliver concentrated amounts of a drug to the brain of rats in a temporary, localized manner using ultrasound.

Read on.

January 19, 2017

Potentially Reversible Changes in Gene Control ‘Prime’ Pancreatic Cancer Cells to Spread

A multicenter team of researchers reports that a full genomic analysis of tumor samples from a small number of people who died of pancreatic cancer suggests that chemical changes to DNA that do not affect the DNA sequence itself yet control how it operates confer survival advantages on subsets of pancreatic cancer cells. Those advantages, the researchers say, let such cancer cells thrive in organs like the liver and lungs, which receive a sugar-rich blood supply.

Read on.

January 11, 2017

New type of CT scanner approved by FDA

Jeffrey Siewerdsen, professor of biomedical engineering, and a team of researchers have designed a new type of CT scanner that has recently been approved for commercial use by the U.S. Food and Drug Administration.

Read on.

Michael Miller: Catching Alzheimer’s Early

Michael Miller, the Herschel and Ruth Sedar Professor of Biomedical Engineering and University Gilman Scholar, is analyzing MRI brain images of the elderly to unveil lurking signs of Alzheimer’s that cognitive tests cannot detect.

Read on.

Tumor Cells

January 7, 2017

Green and Schneck develop a strategy to lengthen lives of mice with skin cancer

Jordan Green, associate professor of biomedical engineering, and Jonathan Schneck, professor of pathology, both at the School of Medicine, have learned that by combining a biomimetic particle along with a more traditional immunotherapy they could lengthen the lives of mice with skin cancer better than either treatment alone. Both approaches focus on activating the rodent immune system killer T cells — white blood cells that fight infection and other invaders.

Read on.